Novo Nordisk A/S: clinical-trial pipeline
Novo Nordisk A/S is the sponsor of 1,418 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 143 are not yet finished and 19 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials143
Phase 2/3 and 3374
Countries79
New in 90 days19
Trials by phase
| Phase | Trials |
|---|---|
| Phase 1 | 468 |
| Phase 3 | 374 |
| Not applicable | 358 |
| Phase 2 | 111 |
| Phase 4 | 104 |
| Phase 1/2 | 2 |
| Early phase 1 | 1 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 1,210 |
| Recruiting | 84 |
| Active, not recruiting | 45 |
| Terminated | 43 |
| Withdrawn or not authorised | 22 |
| Not yet recruiting | 14 |
Condition areas
| Area | Trials |
|---|---|
| Metabolic and endocrine (diabetes, obesity) | 1,106 |
| Haematology | 157 |
| Gastroenterology and liver | 53 |
| Cardiovascular | 52 |
| Women's health and obstetrics | 35 |
| Nephrology and urology | 30 |
| Rare and genetic diseases | 24 |
| Immunology and rheumatology | 21 |
| Neurology | 13 |
| Infectious disease and vaccines | 12 |
| Oncology | 8 |
| Dermatology | 7 |
Countries
| Country | Trials |
|---|---|
| United States | 455 |
| Germany | 433 |
| United Kingdom | 257 |
| Japan | 220 |
| Spain | 218 |
| France | 207 |
| Canada | 197 |
| Italy | 186 |
| Poland | 184 |
| Denmark | 171 |
| India | 156 |
| Netherlands | 135 |
| Austria | 132 |
| South Africa | 121 |
| Russia | 117 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-23 | New trial posted | Efficacy and safety of zenagamtide s.c. once weekly compared to semaglutide s.c. once wee… |
| 2026-10-21 | New trial posted | Efficacy and safety of zenagamtide s.c. once weekly compared to semaglutide s.c. once wee… |
| 2026-10-19 | New trial posted | Semaglutide Health Outcomes and Patient Adherence in Australia |
| 2026-10-09 | New trial posted | A Research Study Investigating How Adults With Overweight or Obesity, With or Without Typ… |
| 2026-10-06 | New trial posted | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With… |
| 2026-10-02 | New trial posted | A research study to evaluate the safety of NNC9836-0001 when given to healthy participant… |
| 2026-10-02 | New trial posted | A Research Study Investigating How Adults With Overweight or Obesity, With or Without Typ… |
| 2026-09-30 | New trial posted | Real-World Patient and Physician Experience With Semaglutide Across Six Emerging Markets |
| 2026-09-29 | New trial posted | A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of… |
| 2026-09-21 | New trial posted | A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A |
| 2026-09-21 | New trial posted | A Study to See How Safe a New Medicine (NNC0642-1895) is in Healthy People |
| 2026-09-21 | New trial posted | A global phase 3 randomised, double-blind and placebo-controlled study evaluating the eff… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06200207 | A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure a… | Phase 3 | Active, not recruiting | Argentina, Australia, Bulgaria, Canada +11 |
| 2023-506962-30-00 | The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitis | Phase 3 | Active, not recruiting | Austria, Belgium, Bulgaria, Czechia +14 |
| 2023-506830-66-00 | A dose-finding trial evaluating the effect and safety of once-weekly treatment of somapacitan compared to dai… | Phase 2 | Active, not recruiting | Austria, France, Hungary, Italy +1 |
| 2023-506929-11-00 | Efficacy and safety of cagrilintide s.c. in combination with semaglutide s.c. (CagriSema s.c.) once-weekly in… | Phase 3 | Active, not recruiting | Belgium, Bulgaria, Germany, Denmark +6 |
| NCT06260709 | A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart… | Phase 2 | Active, not recruiting | Canada, Czechia, Germany, Spain +6 |
| 2023-506925-13-00 | Open-label study investigating efficacy, safety and pharmacokinetics of concizumab prophylaxis in children be… | Phase 3 | Active, not recruiting | Bulgaria, Spain, France, Greece +6 |
| 2023-506927-27-00 | A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well… | Phase 3 | Active, not recruiting | Austria, Belgium, Bulgaria, Germany +12 |
| NCT06118281 | ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack | Phase 3 | Active, not recruiting | Argentina, Australia, Bulgaria, Brazil +19 |
| NCT05669755 | REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and… | Phase 3 | Active, not recruiting | Argentina, Australia, Bulgaria, Brazil +20 |
| NCT06609226 | A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalass… | Phase 3 | Active, not recruiting | Canada, Germany, Egypt, Spain +12 |
| NCT06780449 | A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity | Phase 3 | Active, not recruiting | Belgium, Canada, Denmark, United Kingdom +2 |
| NCT06571383 | STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weig… | Phase 4 | Active, not recruiting | Belgium, Canada, Germany, Denmark +9 |
| NCT07010432 | The Role of the Amylin Analogue Cagrilintide in Bone Metabolism | Phase 1 | Recruiting | Denmark |
| NCT06612268 | A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease | Phase 3 | Recruiting | Australia, Belgium, Brazil, Canada +16 |
| NCT06979375 | A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Hea… | Phase 2 | Recruiting | Australia, Czechia, Germany, Spain +6 |
| NCT06979362 | A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart… | Phase 2 | Recruiting | Canada, Germany, Spain, United Kingdom +5 |
| NCT07448623 | A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Usi… | Phase 1 | Recruiting | Netherlands |
| NCT07076199 | A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to D… | Phase 3 | Active, not recruiting | Australia, Canada, Germany, Poland +4 |
| NCT07112339 | A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal I… | Phase 4 | Recruiting | Canada, Germany, Italy |
| NCT07220564 | A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Hae… | Phase 1 | Active, not recruiting | Austria, Belgium, Switzerland, Germany +8 |
| NCT07220642 | Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide | Phase 3 | Active, not recruiting | Argentina, Australia, Canada, Germany +6 |
| NCT07270731 | A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabet… | Phase 1 | Recruiting | Germany |
| NCT07220759 | Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilin… | Phase 3 | Active, not recruiting | Argentina, Canada, Switzerland, Czechia +7 |
| NCT07207811 | CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-00… | Phase 3 | Recruiting | Argentina, Australia, Belgium, Brazil +16 |
| NCT07656454 | A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Inje… | Phase 1 | Active, not recruiting | Germany |
Website: novonordisk.com. All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Novo Nordisk A/S clinical trials: 143 open, 374 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/novonordisk-com/, data as of 2026-10-25.